title: Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
abstract: Retinoids and retinoic acid receptors (RARs) are important mediators of normal epithelial cell homeostasis. To assess the role of retinoids and RARs in regulating growth arrest and apoptosis in benign and malignant mammary epithelial cells, two model systems were developed: 1) RAR function was suppressed in retinoid-sensitive normal human mammary epithelial cells (HMECs) by the dominant-negative retinoic acid receptor, RARalpha403 (DNRAR), and 2) retinoid-resistant MCF-7 breast cancer cells were transduced with a functional RARbeta2. Inhibition of RAR function by the DNRAR in HMECs resulted in retinoid-resistance, increased proliferation, and dysregulated growth when cells were cultured in reconstituted extracellular matrix (rECM). Expression of RARbeta2 in MCF-7 cells resulted in sensitivity to retinoid-induced growth arrest and apoptosis. The CREB-binding protein (CBP) and the homologous protein p300 are tightly regulated, rate-limiting integrators of diverse signaling pathways and are recruited during retinoid-mediated transcriptional activation. The relationship between retinoid receptor expression, growth regulation, and transcriptional regulation of CBP/p300 is poorly understood. Inhibition of RAR function in HMECs by DNRAR suppressed expression of CBP/p300 and expression of RARbeta2 in MCF-7 cells promoted induction of CBP/p300 when cells were treated with 1.0 microM all-trans-retinoic acid (ATRA). These results suggest that ATRA and RARs regulate growth arrest of HMECs and modulate CBP/p300 protein expression. Since CBP and p300 are normally present in limiting amounts, their regulation by ATRA and RARs may be an important element in the control of transcriptional activation of genes regulating growth arrest and apoptosis.
authors.affiliation: Division of Medical Oncology and Transplantation, Duke University Medical Center, Durham, North Carolina, 27710, USA.
authors.forename: Eric C
authors.initials: EC
authors.lastname: Dietze
authors.forename: L Elizabeth
authors.initials: LE
authors.lastname: Caldwell
authors.forename: Kelly
authors.initials: K
authors.lastname: Marcom
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Collins
authors.forename: Lisa
authors.initials: L
authors.lastname: Yee
authors.forename: Karen
authors.initials: K
authors.lastname: Swisshelm
authors.forename: Katherine B
authors.initials: KB
authors.lastname: Hobbs
authors.forename: Gregory R
authors.initials: GR
authors.lastname: Bean
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Seewaldt
mesh_terms: D017209:Apoptosis; D001940:Breast / Q000166:cytology* / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology; D002455:Cell Division; D004847:Epithelial Cells / Q000473:pathology / Q000502:physiology*; D005260:Female; D005786:Gene Expression Regulation; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D018168:Receptors, Retinoic Acid / Q000378:metabolism*; D012176:Retinoids / Q000378:metabolism*; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D009687:Nuclear Proteins; D018168:Receptors, Retinoic Acid; D012176:Retinoids; D015534:Trans-Activators